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ABSTRACT
A simple and sensitive high performance liquid chromatographic method with reverse-phase column for the simultaneous quantification of caffeic acid, ferulic acid, and isoferulic acid in rabbit plasma was developed. An ODS column (150 mm × 4.6 mm I.D.,
5 µm) was used as the stationary phase and the mobile phase consisted of acetonitrile/glacial acetic acid/water (15:0.5:85, v/v, pH
adjusted to 4.5). Flow-rate was 1.0 mL/min and UV absorbance was set at 321 nm. One hundred microliter of plasma was used
to simultaneously measure the concentrations of caffeic acid, ferulic acid, and isoferulic acid. After a direct clean-up procedure
with 10% of trifluoroacetic acid, the lower limits of quantification were 0.1 µg/mL and the standard curves were found to be linear
over the concentration ranges of 0.1-100 µg/mL for caffeic acid, ferulic acid, and isoferulic acid. The average recoveries for caffeic
acid, ferulic acid, and isoferulic acid were 96.2%, 98.0%, and 98.3%, respectively. The results for all compounds also showed good
stability after three freeze/thaw cycles and storage at ambient temperature and 4°C for 24 hr. The assay method was successfully
applied to the pharmacokinetic study of caffeic acid, ferulic acid, and isoferulic acid after an intravenous administration of caffeic
acid to rabbits.
Key words: caffeic acid, ferulic acid, isoferulic acid, HPLC

INTRODUCTION
Caffeic acid (3,4-dihydroxycinnamic acid, CA) is
found in a wide variety of foods including vegetables,
fruits, tea, coffee, and wine (1-2). Caffeic acid elicits
several interesting and various biological responses, such
as antibacterial(3-4), anti-fungal(5), anti-inflammatory(6),
antiviral(7-8), anticancer (9-10), antioxidant (11-14), antimutagenic (15), and anti-diabetic activities (16). Due to these
biological activities, caffeic acid could be a good lead
compound for new drug development. However, pharmacokinetic studies of caffeic acid and its related methylated metabolites, ferulic acid (FA) and isoferulic acid
(IFA), have not been completely identified and studied.
Various analytical methods have been used for the
determination of CA, FA, and IFA in natural products
including high performance liquid chromatography
(HPLC) and gas chromatography (GC) after derivatization. For analysis of the biological samples, most methods were used to analyze both caffeic acid and ferulic
* Author for correspondence. Tel: +886-2-27361661 ext. 6133;
Fax: +886-2-27370903; E-mail: shwu-lin@tmu.edu.tw

acid (17-19) or ferulic acid and isoferulic acid in plasma or
urine (20-21). However, reports on the simultaneous analysis of CA, FA, and IFA in biological samples are scarce.
A recent study to determine CA, FA, and IFA in human
plasma as metabolites was derived from artichoke leaf
extract (21). This method involved sample preparation
followed analysis using high performance liquid chromatography on reversed-phase material with a polar endcapping (Aqua-C18). The target compounds were monitored
by electrochemical array detection (CoulArray). Calibration curves of caffeic acid, ferulic acid, and isoferulic
acid were conducted in the ranges of 2.1-51.7 ng/mL, 2.253.7 ng/mL, and 1.1-52.6 ng/mL, respectively. Although
this assay method shows high sensitivity; it needs about
500 µL of plasma and a complicated preparation procedure. It is also time consuming with one sample for total
analytical time about 97.5 min including HPLC analysis
taken over 87.5 min and column flushing about 10 min.
In an animal model of our studies, the volume of biological sample is sparse. Thus, in order to develop a suitable
method for the determination of metabolites in a metabolic study of caffeic acid after intravenous administration to rabbits and in accordance with the international
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guidelines for validation of bioanalytical methods (22),
a simple and sensitive analytical method for simultaneously determining CA, FA, and IFA in biological samples
was conducted.

and vortex mixed for 1 min. Samples were centrifuged at
1,945 ×g for 10 min. An aliquot (25 µL) of supernatant
was injected into the HPLC system.

MATERIALS AND METHODS

Caffeic acid (CA) and ferulic acid (FA) were obtained
from Sigma (St. Louis, MO, USA). Isoferulic acid (IFA)
was purchased from Lancaster Synthesis (Lancashire,
UK). Acebutolol used as the internal standard was
supplied by the Coprima Sociedad Anónima (Barcelona,
Spain). HPLC grade of acetonitrile, trifluoroacetic acid
(TFA), phosphoric acid (85%), glacial acetic acid, and 2aminoethanol were obtained from E. Merck (Darmstadt,
Germany). All other chemicals were of analytical grade
and used without further purification.

A standard curve was prepared by the addition of
known quantities of CA-FA-IFA mixture to aliquots of
plasma and prepared as described above for sample preparation. The concentration used for each sample was 0.1,
0.2, 0.5, 2, 5, 20, 50, and 100 µg/mL. The peak-height
ratios of each compound to internal standard were plotted against the concentration of each compound prepared.
Linearity was determined for all concentrations (0.1-100
µg/mL). The standard curve of each compound was determined by weighted least-square linear regression analysis
corresponding to 1 over concentration square (1/concentration 2). The concentrations of CA, FA or IFA in the test
samples were calculated using the regression parameters
of CA, FA or IFA itself obtained from the standard curve.

II. Apparatus and Chromatographic Conditions

VI. Accuracy and Precision

The HPLC system consisted of a Shimadzu LC10ADVP pump, SIL-HTA /HTC autosampler, SPD10AVP/10AV VP UV detector, and CLASS-VP Ver.6.1
system manager as data processor (Shimadzu Co., Kyoto,
Japan). Separation was achieved by a Biosil Pro-ODSU column (150 mm × 4.6 mm I.D., 5 µm, Biotic Chemical Co., Ltd., Taipei, Taiwan). A mobile phase composed
of acetonitrile/glacial acetic acid/water (15:0.5:85, v/v,
pH 4.5) was used throughout the analysis. Flow rate was
1.0 mL/min and UV absorbance was set at 321 nm. The
mobile phase was filtered and degassed before use.

Four different concentrations (0.1, 0.3, 4 and 80 µg/
mL) of CA, FA, and IFA were prepared with drug-free
plasma and the concentrations were determined using the
corresponding standard curves. Accuracy of the method
was shown in relative errors (RE) which was calculated
based on the difference between the mean calculated and
added concentrations, while precision was evaluated by
within- and between-run coefficient of variation (CV).

I. Chemicals and Reagents

III. Preparation of Solution
Stock solutions of CA (1 mg/mL) and FA (1 mg/
mL) were separately prepared by weighing 10 mg of
CA or FA into a calibrated 10-mL volumetric flask and
making volume to 10 mL with acetonitrile/85% phosphoric acid/water (10:0.01:90, v/v). Stock solution of IFA
(1 mg/mL) was prepared by weighing 10 mg of IFA into
a calibrated 10-mL volumetric flask and making volume
to 10 mL with acetonitrile/85% phosphoric acid/water
(25:0.01:90, v/v). Working solutions of CA, FA, and IFA
were prepared by further dilution of each standard stock
solution with acetonitrile/water (10:90, v/v) to 0.01, 0.1,
and 1 µg/mL. Solutions were stored at 4°C until analysis.
IV. Sample Preparation
One hundred microliter of plasma were spiked into
a clean culture tube and subsequently 15 µL of internal
standard solution [10 ng/µL of acebutolol in 10% (v/v) of
TFA] were added and mixed well. One hundred microliter of 10% (v/v) of trifluoroacetic acid were then added

V. Standard Curve

VII. Recovery
Recovery was calculated by comparing the peakheight of each compound in the plasma to that of the
equivalent amounts in the aqueous solution.
VIII. Freeze/thaw Stabilities and Post-Preparation Stability
Freeze and thaw stability was tested by spiking samples
at the concentrations of 0.15 and 80 µg/mL through three
freeze/thaw cycles. Post-preparation stability was tested by
plasma samples at the concentrations of 0.3 and 80 µg/mL,
which were kept on bench at room temperature (25°C) and
in a freezer at 4°C for 24 hr after preparation, respectively.
IX. Rabbits Experiment
Male New Zealand white rabbits which weighed 1.82.0 kg were used in pharmacokinetic studies. Before single
intravenous administration of 10 mg/kg of caffeic acid,
the rabbits were fasted overnight. Blood samples (1.0 mL)
were collected at the following times: 0 (pre-drug), 5, 10,
20, 30, 60, 90, 120, 180, 240, 360, and 600 min from the
marginal vein of the ear after intravenous administration,
and placed into an ice bath immediately. Plasma was sepa-
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RESULTS AND DISCUSSION
I. Sample Preparation
The chemical structures of caffeic acid, ferulic acid
and isoferulic acid are shown in Figure 1. As previously
reported(23), CA has a fast degradation rate in higher
pH solution and it is stable in the buffer solution with pH
range of 2-5. Therefore, FA and IFA could also have the
same properties. When the sample solutions were not of
sufficient acidity, these hydroxycinnamates were present
as protonated and nonprotonated species and subsequently
degraded easily(21). During the development of analytic
method for simultaneous determination of CA, FA and IFA
in rabbit plasma, we found that most commonly used solidphase extraction was time-consuming and resulted in lower
recovery and higher LOD. On the other hand, using acetonitrile as a protein-precipitating reagent would produce
endogenous interference and/or low recovery. However,
using TFA as a sample clean-up reagent could maintain
post preparative sample in acidic condition and subsequently keep the stabilities of CA, FA, and IFA. Therefore,
it could save concentration time of post sample preparation
and simplify sample preparation procedure. After optimization, a pH value of the mobile phase at 4.5 was used. The
baseline separation of CA, FA, IFA, a clear and sharp peak,
good analytical sensitivity and no interference peak were
obtained within a run-time of 20 min. Typical chromatograms are shown in Figure 2. No significant endogenous
peak co-eluted with the target compounds as shown in the
corresponding chromatogram of drug-free plasma. The
retention times for CA, FA, IFA, and internal standard were
5.05, 10.94, 12.63 and 14.55 min, respectively.

0.010

The method was validated for the concentration range
of 0.1-100 µg/mL. A linear regression was performed
using the equation y = a + bx by weighted (1/x 2) over the
standard curve range. The coefficients of determination obtained from the standard curve used in within-run
and between-run validations, respectively, were greater
than the value of 0.99. A statistical linear regression was
performed for each compound using concentration against
peak height ratio of target compound to internal standard.
Three linear regression equations (y = a + bx; y = peak
height ratio, x = concentration) were b = 0.2792 ± 0.0041,
a = -0.0010, r2 = 0.9962 for CA, b = 0.1392 ± 0.0004, a =
0.0039, r2 = 0.9983 for FA, and b = 0.1174 ± 0.0010, a =
0.0000, r2 = 0.9983 for IFA. The results indicated linear
relationship between peak height ratio and concentration
over the concentration range of 0.1-100 µg/mL.
III. Precision and Accuracy
The detailed precision and accuracy data of CA, FA
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Figure 1. Chemical structures of caffeic acid, ferulic acid, isoferulic
acid and acebutolol (internal standard).
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Figure 2. Typical chromatograms of (A) authentic compound, (B) drug-free plasma, (C) caffeic acid, ferulic acid, and isoferulic acid plasma,
concentration at 4 µg/mL with internal standard. 1. caffeic acid; 2. ferulic acid; 3. isoferulic acid; 4. internal standard.
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and IFA for within- and between-run are shown in Tables
1 and 2. In higher concentrations, both within- and
between-run CV values were 1.4-3.4% for CA, 1.2-3.9%
for FA, and 1.2-4.4% for IFA. The within- and betweenrun RE values were -3.9 to 7.3% for CA, -6.1 to 3.6% for
FA, and -5.5 to 3.6% for IFA at three different concentration levels. These results indicated that the present
method yields the acceptable precision and accuracy.
IV. Lower Limitation of Quantification (LLOQ)
The lower limitation of quantification (LLOQ) was
defined as the lowest concentration on the standard curve
that could be determined with acceptable precision and
accuracy. Thus, the LLOQs all were 0.1 µg/mL for CA,
FA, and IFA. At LLOQ level, CVs were 2.50–12.6%

and RE values–11.7 to 19.4%. Precision and accuracy of
within- and between-run at the LLOQ for CA, FA, and
IFA met the requirements (both CV and RE ≤ 20%) for
bioanalytical analysis(22).
V. Recovery
As shown in Table 3, after the direct de-protein
procedure with 10% (v/v) of TFA solution, recoveries of
CA, FA, and IFA at three different concentrations were
93.9-98.2%, 95.6-101.2%, 96.5-100.9%, respectively.
The average recoveries of CA, FA, and IFA were 96.2%,
98.0%, and 98.3%, respectively. These results indicated
that the direct de-protein procedure using 10% (v/v) of
TFA solution is a good preparation method.

Table 1. Data for within-run precision and accuracy
Nominal concentration (µg/mL)
Caffeic acid
Run
I

II

III

Ferulic acid

Isoferulic acid

0.1

0.3

4

80

0.1

0.3

4

80

0.1

0.3

4

80

Mean

0.100

0.288

3.88

85.9

0.108

0.294

3.89

82.9

0.095

0.284

3.95

82.9

S.D.

0.004

0.004

0.05

1.8

0.003

0.008

0.07

1.0

0.007

0.009

0.06

1.1

CV (%)

4.4

1.5

1.4

2.1

3.0

2.6

1.8

1.2

7.5

3.2

1.5

1.4

RE (%)

0.3

-3.9

-3.0

7.3

8.1

-2.1

-2.8

3.6

-5.3

-5.5

-1.2

3.6

Mean

0.102

0.298

3.95

82.2

0.088

0.282

4.00

81.2

0.116

0.310

4.01

79.8

S.D.

0.004

0.006

0.08

2.0

0.007

0.010

0.05

1.4

0.010

0.006

0.05

1.1

CV (%)

3.7

2.1

2.1

2.4

8.2

3.5

1.3

1.7

8.2

1.8

1.2

1.4

RE (%)

2.5

-0.6

-1.1

2.7

-11.7

-6.1

0.0

1.5

16.2

3.4

0.2

-0.2

Mean

0.119

0.307

3.88

80.9

0.104

0.292

3.94

81.6

0.104

0.293

3.94

80.8

S.D.

0.003

0.007

0.06

1.5

0.013

0.011

0.07

1.5

0.006

0.006

0.05

1.5

CV (%)

2.5

2.3

1.4

1.8

12.6

3.9

1.8

1.8

5.4

2.0

1.2

1.9

RE (%)

19.4

2.3

-3.1

1.1

3.7

-2.6

-1.5

2.0

4.4

-2.5

-1.5

1.0

n = 6 for each concentration and run.

Table 2. Data for between-run precision and accuracy
Caffeic acid

a

Ferulic acid

Isoferulic acid

Nominal
concentration
(µg/mL)

Calculated
concentration
(mean ± S.D.)
(µg/mL)

C.V.a
(%)

Relative
errorb
(%)

Calculated
concentration
(mean ± S.D.)
µg/mL)

C.V. a
(%)

Relative
errorb
(%)

Calculated
concentration
(mean ± S.D.)
(µg/mL)

C.V. a
(%)

0.1

0.107 ± 0.009

8.4

7.0

0.104 ± 0.013

12.5

4.0

0.105 ± 0.012

11.4

5.0

0.3

0.298 ± 0.010

3.4

-0.7

0.292 ± 0.011

3.8

-2.7

0.295 ± 0.013

4.4

-1.7

4

3.90 ± 0.07

1.8

-2.4

3.94 ± 0.07

1.8

-1.5

3.97 ± 0.06

1.4

-0.9

80

83.0 ± 2.7

3.3

3.7

81.6 ± 1.5

1.8

2.0

81.2 ± 1.8

2.2

1.5

CV = 100% × (S.D./mean).
Relative error = 100% × (concentration calculated – spiking plasma concentration)/spiking plasma concentration.
c
n = 18 for each concentration.
b

Relative
errorb
(%)
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Table 3. Recoveries for caffeic acid, ferulic acid, and isoferulic acid
Caffeic acid
Nominal
concentration
(µg/mL)
0.3
4
80

Ferulic acid

Isoferulic acid

Water
sample
Peak height

Plasma
sample
Peak height

Recovery
(%)

Water
sample
Peak height

Plasma
sample
Peak height

Recovery
(%)

Water
sample
Peak height

Plasma
sample
Peak height

Recovery
(%)

495 ± 3

486 ± 5

98.2

261 ± 5

264 ± 13

101.2

214 ± 3

216 ± 9

100.9

6761 ± 235

6349 ± 90

93.9

3356 ± 98

3262 ± 33

97.2

2866 ± 103

2791 ± 43

97.4

139947 ± 2025 135001 ± 4116

96.5

69824 ± 925 66783 ± 2139

95.6

59172 ± 628 57092 ± 1781

96.5

n = 3 for each concentration.

Table 4. Freeze and thaw stabilities of target compounds
Nominal concentration (µg/mL)
Caffeic acid

a

Ferulic acid

Isoferulic acid

Cycle

0.15

80

0.15

80

0.15

80

Initial

0.145 ± 0.010

80.5 ± 2.9

0.131 ± 0.007

78.0 ± 1.6

0.161 ± 0.013

75.4 ± 1.5

1
REa (%)

0.137 ± 0.005
-5.39%

83.1 ± 2.3
3.27%

0.125 ± 0.020
-4.54%

79.6 ± 3.1
2.09%

0.160 ± 0.007
-0.14%

76.4 ± 2.5
1.29%

2
RE (%)

0.148 ± 0.005
1.77%

81.9 ± 0.9
1.80%

0.126 ± 0.015
-3.96%

79.8 ± 2.2
2.36%

0.161 ± 0.011
0.11%

77.1 ± 1.7
2.23%

3
RE (%)

0.139 ± 0.009
-4.43%

84.2 ± 1.5
4.68%

0.136 ± 0.020
3.56%

81.2 ± 2.6
4.18%

0.158 ± 0.007
-1.83%

78.0 ± 3.0
3.41%

RE (%) = 100% × (concentration calculated – initial plasma concentration)/initial plasma concentration.
n = 3 for each concentration and cycle.

b

Table 5. Post-preparation stability after storage at room temperature and 4°C for 24 hr
Nominal concentration (µg/mL)
Caffeic acid

a

Ferulic acid

Isoferulic acid

Cycle

0.3

80

0.3

80

0.3

80

Initial

0.287 ± 0.006

81.2 ± 1.4

0.280 ± 0.008

83.4 ± 0.5

0.285 ± 0.002

81.3 ± 0.3

Room temperature
REa (%)

0.302 ± 0.006
5.22%

86.4 ± 1.1
6.39%

0.300 ± 0.008
7.14%

86.4 ± 0.6
3.64%

0.304 ± 0.003
6.67%

86.5 ± 0.5
6.45%

4°C
RE (%)

0.299 ± 0.005
4.18%

85.5 ± 0.5
5.21%

0.301 ± 0.020
7.50%

85.8 ± 0.5
2.90%

0.292 ± 0.006
2.46%

85.5 ± 0.5
5.16%

RE (%) = 100% × (concentration calculated – initial plasma concentration)/initial plasma concentration.
n = 3 for each concentration and cycle.

b

VI. Freeze and Thaw Stability
The freeze and thaw stability study indicated a shortterm stability of the target compounds in plasma samples
in the thaw procedure. Furthermore, some plasma
protein can coagulate and precipitate after freezing and
thawing, respectively. Because the target compounds
can bind to the plasma protein, the phenomena of plasma
protein coagulating in the frozen condition and precipitating after thawing to room temperature can result in
concentration loss. As shown in Table 4, the differences

of the measured concentrations for the target compounds
between the initial and each cycle were less than 10% for
two concentrations. This indicated that these compounds
have good stability in plasma samples after three freeze
and thaw cycles.
VII. Post-Preparation Stability
Post-preparation stability was used to evaluate the
plasma sample stability after preparation. Plasma samples
were prepared at concentrations of 0.3 µg/mL and 80 µg/
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VIII. Test Results
The procedure was applied in pharmacokinetic studies by IV administration of CA to rabbits. Typical plasma
concentration-time profiles of CA, FA, and IFA are shown
in Figure 3. The plasma concentrations of CA, FA,
and IFA were in the standard curve range. The plasma
concentrations remained above the 0.1 µg/mL lower limit
of quantification (LLOQ) for the entire sampling period.
The method developed by Wittemer et al.(21)
required 500 µL of plasma and a complicated preparation
procedure. In an animal model, the volume of biological sample was sparse. Therefore, this method could not
apply to the animal studies. On the contrary, our developed method provides many advantages such as simple
and fast sample preparation procedure. It also avoids the
sample lost and decreases the analytic variance.
The results demonstrated that this method is simple,
sensitive, precise and accurate and reproducible. From
the data obtained after IV administration of CA to
rabbits, it is concluded that the method described herein
offers the opportunity to derive pharmacokinetic parameters with an acceptable accuracy and precision.

CONCLUSIONS
In the present study, the developed method was validated in accordance with international guidelines for the
validation of bioanalytical methods (22), and was used for
the determination of metabolites in a metabolic study of
caffeic acid after intravenous administration to rabbits.
The standard curves for each target compound showed
a linear relationship over the concentration range of 0.1100 µg/mL. Thus, this method could provide a good
precision, accuracy, and reproducible assay for the simultaneous quantification of caffeic acid, ferulic acid, and
isoferulic acid in rabbit plasma after intravenous administration of caffeic acid.
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mL for each target compound and stored at 4°C and 25°C.
Stability was monitored after 24 hr. Plasma samples
stored at 4°C and room temperature for 24 hr showed
good stabilities. The RE (%) ranged from 2.46 to 7.50%,
showing that processed QC samples kept at 4°C and room
temperature (25°C) were stable for at least 24 hr.
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Figure 3. Plasma concentration-time profiles of caffeic acid, ferulic
acid, and isoferulic acid, respectively, after a single intravenous
administration of 10 mg/kg of caffeic acid to one rabbit.
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